Subscribe X
Back to Top



August 7, 2013 by Janine Francolini

Will You Be Our Heroes? Dr. Phil, Dr. Oz and Mr. Williams

Janine-FrancoliniThis post is being written as an open letter to Brian Williams, Dr. Oz and Dr. Phil about their recent portrayal on their shows of people living with mental illness.

Dear Dr. Phil, Dr. Oz and Mr. Williams,

As you read this, you may be bracing yourselves for yet another attack and demand for a public apology for your recent ill-informed comments about people who live with mental health challenges. Gentleman, don’t, as I am not reaching out to you for that reason. I am writing to share all of the good that has happened since we launched this dialogue just a few days ago.

Read More

August 4, 2013 by Sandra Steingard, MD

Can Psychiatry “Re-Engage” with Pharma?

On August 1, Jeffrey Lieberman, M.D., the current President of the American Psychiatric Association,  wrote an open letter to Psychiatry News asking whether is was time for psychiatry to “re-engage with pharma”.

Dr. Lieberman asserts that although there are problems with the way the public perceives drug companies, he thinks it is time for psychiatry to re-evaluate  its connections to the industry.  He reports on a recent meeting of the American Psychiatric Foundation Corporate Advisory Council with representatives of 14 pharmaceutical companies.

Read More

March 31, 2013 by Sandra Steingard, MD

Optimal Use of Neuroleptic Drugs, Pt. II: The Monkeys Were Not Psychotic

I asserted previously that the impression of short term efficacy tends to be inflated. What I mean by this is that there is a general sense – within my profession and among the general public – that neuroleptic drugs are very effective. They are after all what allowed us to shutter our state hospitals. The folk narrative is that the main problem is not that they do not work but that people do not take them reliably so we should therefore put our efforts into getting people to stay on them.

Read More

March 25, 2013 by Sandra Steingard, MD

Optimal Use of Neuroleptic Drugs: An Introduction

I have recently put together a talk in which I summarize my current thinking on the optimal use of neuroleptic drugs, primarily focusing on the treatment of individuals who are experiencing psychotic symptoms. In order to foster conversation on this topic, I will be posting the content of this talk in a series of blogs.

Read More

January 15, 2013 by Courtenay Harding, PhD

Why Is It So Hard to Believe in Recovery? Part I

A long time ago in a galaxy far away, I was a nurse at in the neurosurgical unit at Boston’s famous Children’s Hospital. One afternoon, we received a semi-comatose patient named Charlie in our ICU. He was 15, and apparently a really good kid from a terrible neighborhood in Roxbury, a section of Boston next door to us. He and his best friend had found a gun in a trash can. They thought that they had checked the gun barrel for bullets and proceeded to play a game of Russian Roulette. The friend put the gun between his own eyebrows and pulled the trigger.

Read More

Related Blogs

  • Dr. David Healy

    Dr. David Healy

    Dr. Healy is a professor of psychiatry at Cardiff University in Wales and an author on the history of pharmaceuticals and government regulation.
  • Mad In America: Robert Whitaker

    Mad In America: Robert Whitaker

    Journalist and author Bob Whitaker distills the latest in pharmaceutical and mental health research.
  • Selling Sickness

    Selling Sickness

    Creating a new partnership movement to challenge the selling of sickness.
  • Kathy Brous

    Kathy Brous

    A serial of Kathy's recovery journey as an adult with attachment disorder.
  • Nev Jones

    Nev Jones

    Exploring the intersections of psychiatry, philosophy, neuroscience, cultural theory, critical community psychology and the mad/user/survivor movement.
  • 1boringoldman


    Retired psychiatrist and raconteur offers insightful analysis of the day's events from the woods of Georgia.